Literature DB >> 21517986

Advances in pediatric renal replacement therapy for acute kidney injury.

Stuart L Goldstein1.   

Abstract

The disease spectrum leading to pediatric renal replacement therapy (RRT) provision has broadened over the last decade. In the 1980s, intrinsic renal disease and burns comprised the most common pediatric acute renal failure etiologies; more recent data demonstrate that pediatric acute kidney injury (AKI) most often results from complications of other systemic diseases resulting from the advancements in congenital heart surgery, neonatal care, and bone marrow and solid organ transplantation. In addition, RRT modality preferences to treat critically ill children have shifted from peritoneal dialysis to continuous renal replacement therapy (CRRT) as a result of improvements in CRRT technologies. In this article, we aim to review the pediatric specific causes for RRT provision, emphasizing the emerging practice patterns with respect to modality and timing of treatment. We will focus on the application of different RRT modalities and related outcome of children with AKI who receive RRT.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517986     DOI: 10.1111/j.1525-139X.2011.00834.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  15 in total

Review 1.  Renal angina: an emerging paradigm to identify children at risk for acute kidney injury.

Authors:  Rajit K Basu; Lakhmir S Chawla; Derek S Wheeler; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2011-10-20       Impact factor: 3.714

Review 2.  Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!

Authors:  Vijay Srinivasan
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 3.  Dialysis modalities for the management of pediatric acute kidney injury.

Authors:  Lara de Galasso; Stefano Picca; Isabella Guzzo
Journal:  Pediatr Nephrol       Date:  2019-03-18       Impact factor: 3.714

Review 4.  Continuous renal replacement therapy in children.

Authors:  Scott M Sutherland; Steven R Alexander
Journal:  Pediatr Nephrol       Date:  2012-02-28       Impact factor: 3.714

5.  Acute dialysis in children: results of a European survey.

Authors:  Isabella Guzzo; Lara de Galasso; Sevgi Mir; Ipek Kaplan Bulut; Augustina Jankauskiene; Vilmanta Burokiene; Mirjana Cvetkovic; Mirjana Kostic; Aysun Karabay Bayazit; Dincer Yildizdas; Claus Peter Schmitt; Fabio Paglialonga; Giovanni Montini; Ebru Yilmaz; Jun Oh; Lutz Weber; Christina Taylan; Wesley Hayes; Rukshana Shroff; Enrico Vidal; Luisa Murer; Francesca Mencarelli; Andrea Pasini; Ana Teixeira; Alberto Caldas Afonso; Dorota Drozdz; Franz Schaefer; Stefano Picca
Journal:  J Nephrol       Date:  2019-04-04       Impact factor: 3.902

6.  Secular Trends in Incidence, Modality and Mortality with Dialysis Receiving AKI in Children in Ontario: A Population-Based Cohort Study.

Authors:  Rahul Chanchlani; Danielle Marie Nash; Eric McArthur; Michael Zappitelli; Victoria Archer; John Paul Kuwornu; Amit X Garg; Jason H Greenberg; Stuart L Goldstein; Lehana Thabane; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-23       Impact factor: 8.237

Review 7.  Clinical Pharmacology Studies in Critically Ill Children.

Authors:  Nilay Thakkar; Sara Salerno; Christoph P Hornik; Daniel Gonzalez
Journal:  Pharm Res       Date:  2016-09-01       Impact factor: 4.200

Review 8.  Pediatric renal replacement therapy in the intensive care unit.

Authors:  Brian C Bridges; David J Askenazi; Jessimene Smith; Stuart L Goldstein
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

Review 9.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

10.  Development of an accurate fluid management system for a pediatric continuous renal replacement therapy device.

Authors:  Arvind Santhanakrishnan; Trent T Nestle; Brian L Moore; Ajit P Yoganathan; Matthew L Paden
Journal:  ASAIO J       Date:  2013 May-Jun       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.